Sign In
Get Clay Free →

Suggestions

    Joshua Cohen

    CEO and Founder at Amylyx Pharmaceuticals

    Joshua Cohen is the Co-CEO and Co-Founder of Amylyx Pharmaceuticals Inc., known for inventing and developing the groundbreaking therapy AMX0035.

    With a background in Biomedical Engineering from Brown University, Joshua has demonstrated a deep understanding of medical technology and research.

    Throughout his career, Joshua has successfully led initiatives in the pharmaceutical industry, previously working as an Engineering Researcher at NIST and later founding Clara Health, where he served as an Advisor.

    Under his leadership at Amylyx Pharmaceuticals, Joshua, along with his co-founder Justin Klee, has navigated the development of AMX0035 through rigorous clinical trials, receiving guidance from the ALS and Alzheimer's Communities.

    Joshua Cohen's dedication to advancing therapies for neurological conditions like ALS and Alzheimer's is underscored by his commitment to building strong collaborative relationships within the medical community.

    Joshua Cohen
    Add to my network

    Location

    Canton, Massachusetts, United States